17th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems

Date: February 1-2, 2019.
Location: Mumbai, India

As part of the Controlled Releases Alliance, DuPont alongside long-term partner, Colorcon, are proud to be a platinum sponsor of the 17th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems hosted by Controlled Release Society-Indian Chapter (CRS-IC).

As a chapter of CRS Inc. USA, a not-for-profit organization devoted to the science and technology of controlled release. CRS-IC was established in 1994, with the aim to unite pharmaceutical, chemical and biomedical scientists to advance the science of Controlled Release, towards betterment of global healthcare. CRS-IC offers a platform to students to strengthen their research capabilities and also offers opportunities for business collaborations with technology driven pharmaceutical manufacturers and allied industry.

Today, CRS has its chapters in 16 countries across the world with over 4000 members across the globe. Do not miss the opportunity to connect with DuPont and Alliance experts who will be available throughout the CRS-IC Symposium.

Find out more here.

Recent Events

Fi Europe 2019

CPhI India

Dairy Vision 2019

Bakery Business 2019

Get Started

First Name *

Last Name *

Company *

Email *

Country *

State *

Territory *

How can we help?

Yes, I would like to receive email communication from DuPont Nutrition & Biosciences. I agree to the Privacy Policy and to DuPont Nutrition & Biosciences getting in contact with me.

DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in chosen customer systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected third parties in other countries to provide you with the product or service information requested. To learn more, please visit www.privacy.dupont.com. By providing your personal information, you agree to the terms and conditions of this Privacy Statement.